Human intervention for the investigation of cyclolinopeptide uptake from flaxseed

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00015179

Enrollment

Registered

2018-09-03

Start date

2018-08-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Group 1: consumption of 3 muffins (containing 3x5g linseed)

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: healthy women and men, age between 20 and 40 years, written confirmed consent

Exclusion criteria

Exclusion criteria: acute illness; under- and overweight persons (BMI 30 kg/m2); disorders affecting absorption, digestion, metabolism, and excretion; regular medication except oral contraceptive; known allergy against flaxseed and/or an ingredient of the muffins

Design outcomes

Primary

Measure	Time frame
maximum concentration of cyclolinopeptides (Cmax), time til Cmax (tmax), areau under the curve (AUC), eliminationrate (kel), and elimination-half-life (t1/2) in blood and urine	—

Secondary

Measure	Time frame
flaxseed biomarkers	—

Countries

Germany

Contacts

Public ContactKarin Kleigrewe

Technische Universität MünchenBayerisches Zentrum für Biomolekulare Massensprktrometrie(BayBioMS), Lehrstuhl für Molekulare Sensorik und Lebensmittelchemie

Karin.Kleigrewe@tum.de08161-716130

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026